The US saw several new and expanded FDA indications this year. The top 5 most-read FDA approvals on AJMC.com included 4 novel ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), ...

Sports Mole previews Wednesday's Africa Cup of Nations clash between Sudan and Burkina Faso, including predictions, team news ...

Curious to know which obesity stories grabbed the attention of readers this year? Medscape Medical News develops a list of ...

Abstract: This paper presents improvements to two-stage algorithms for estimating the short-time Fourier transform (STFT) phase from only the amplitude by using deep neural networks (DNNs). The phase ...

Tottenham boss Thomas Frank speaks exclusively to Sky Sports about his side being in a transition phase - but why he is ...

Historically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline in neurological function that ...

Maharashtra Nagar Parishad, Nagar Palika, Panchayat Election Results 2025 Live Updates: Poll results are a trailer of what is ...

The high-profile, much-debated arena renovation provided an upbeat note in the city at a time when the challenges of soaring ...

The FDA has expanded the approval of Addyi to include the treatment of hypoactive sexual desire disorder in women less than 65 years.

Eli Lilly reports Phase 3 data showing oral obesity drug orforglipron maintained weight loss after Wegovy or Zepbound, beating placebo.